X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (192) 192
cardiac & cardiovascular systems (173) 173
index medicus (133) 133
percutaneous coronary intervention (129) 129
male (107) 107
female (98) 98
middle aged (98) 98
aged (79) 79
intracoronary (77) 77
treatment outcome (74) 74
myocardial infarction - therapy (64) 64
myocardial infarction (61) 61
angioplasty (59) 59
coronary angiography (59) 59
primary angioplasty (59) 59
abciximab (52) 52
heart attack (49) 49
cardiology (45) 45
reperfusion (45) 45
angioplasty, balloon, coronary (44) 44
heart attacks (44) 44
intravenous bolus abciximab (43) 43
acute myocardial-infarction (42) 42
mortality (40) 40
electrocardiography (35) 35
stents (35) 35
acute myocardial infarction (33) 33
cardiovascular (33) 33
myocardial infarction - mortality (31) 31
myocardial infarction - physiopathology (31) 31
prognosis (31) 31
time factors (31) 31
risk factors (30) 30
transluminal angioplasty (30) 30
cardiac patients (29) 29
follow-up studies (28) 28
platelet aggregation inhibitors - administration & dosage (28) 28
coronary vessels (27) 27
prospective studies (27) 27
care and treatment (26) 26
intracoronary thrombus (26) 26
medicine & public health (26) 26
microvascular obstruction (26) 26
randomized controlled trials as topic (26) 26
distal embolization (25) 25
elevation myocardial-infarction (25) 25
myocardial infarction - drug therapy (25) 25
thrombectomy (25) 25
intracoronary abciximab (24) 24
therapy (24) 24
antibodies, monoclonal - administration & dosage (23) 23
immunoglobulin fab fragments - administration & dosage (23) 23
no-reflow phenomenon (23) 23
peripheral vascular disease (23) 23
platelet aggregation inhibitors - therapeutic use (23) 23
thrombosis (23) 23
coronary circulation (22) 22
intracoronary adenosine (22) 22
trial (22) 22
magnetic resonance imaging (21) 21
no-reflow (21) 21
adenosine (20) 20
myocardial infarction - diagnosis (20) 20
percutaneous coronary intervention - adverse effects (20) 20
pharmacology & pharmacy (20) 20
thrombolytic therapy (20) 20
abridged index medicus (19) 19
analysis (19) 19
myocardial infarction - surgery (19) 19
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (19) 19
randomized-trial (19) 19
reperfusion injury (19) 19
cardiovascular diseases (18) 18
intervention (18) 18
intracoronary thrombectomy (18) 18
unstable angina (18) 18
antibodies, monoclonal - therapeutic use (17) 17
glycoprotein iib/iiia inhibitors (17) 17
immunoglobulin fab fragments - therapeutic use (17) 17
left-ventricular function (17) 17
risk assessment (17) 17
coronary thrombosis - therapy (16) 16
injections, intra-arterial (16) 16
microcirculation (16) 16
outcomes (16) 16
primary percutaneous coronary intervention (16) 16
size (16) 16
thrombectomy - methods (16) 16
cardiology and cardiovascular medicine (15) 15
coronary heart disease (15) 15
coronary thrombosis - diagnostic imaging (15) 15
hematology (15) 15
intravascular ultrasound (15) 15
myocardial reperfusion - methods (15) 15
adult (14) 14
angioplasty, balloon, coronary - adverse effects (14) 14
angioplasty, balloon, coronary - methods (14) 14
clinical-outcomes (14) 14
primary pci (14) 14
st elevation myocardial infarction - therapy (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation: Cardiovascular Interventions, ISSN 1941-7640, 10/2013, Volume 6, Issue 5, pp. 527 - 534
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 2/2007, Volume 23, Issue 1, pp. 57 - 63
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2013, Volume 168, Issue 3, pp. 2872 - 2872
Journal Article
Journal Article
Vascular Pharmacology, ISSN 1537-1891, 2015, Volume 73, pp. 32 - 37
Abstract Background Although intracoronary abciximab failed to improve prognosis compared with intravenous route in unselected ST-segment elevation myocardial infarction (STEMI... 
Cardiovascular | Acute myocardial infarction | Intracoronary administration | Abciximab | MORTALITY | REVASCULARIZATION | METAANALYSIS | RANDOMIZED-TRIALS | THROMBECTOMY | NO-REFLOW PHENOMENON | HYPERGLYCEMIA | PLATELET-RICH CLOTS | INTRAVENOUS BOLUS ABCIXIMAB | PRIMARY ANGIOPLASTY | REPERFUSION | PHARMACOLOGY & PHARMACY | EXPRESSION | Recurrence | Myocardial Infarction - mortality | Percutaneous Coronary Intervention - mortality | Humans | Immunoglobulin Fab Fragments - adverse effects | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Myocardial Infarction - therapy | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Coronary Thrombosis - prevention & control | Female | Diabetes Mellitus - diagnosis | Diabetes Mellitus - mortality | Odds Ratio | Platelet Aggregation Inhibitors - adverse effects | Myocardial Infarction - diagnosis | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Chi-Square Distribution | Randomized Controlled Trials as Topic | Administration, Intravenous | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Aged | Coronary Thrombosis - etiology | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Diabetics | Care and treatment | Diabetes | Heart attack
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2013, Volume 168, Issue 4, pp. 4410 - 4410
Journal Article
Journal Article
Netherlands Heart Journal, ISSN 1568-5888, 10/2006, Volume 14, Issue 10, pp. 343 - 344
Here we report the potential benefits of the use of intracoronary abciximab during percutaneous coronary intervention for an acute myocardial infarction. 
Abciximab (intracoronary) | Myocardial infarction (acute) | Thrombus | PCI | myocardial infarction (acute) | thrombus | abciximab (intracoronary) | Case Report
Journal Article
Thrombosis Research, ISSN 0049-3848, 2013, Volume 132, Issue 1, pp. e36 - e41
... percutaneous coronary intervention. We sought to evaluate the extent of platelet inhibition by a blocking and bridging strategy with intracoronary abciximab bolus-only administration and oral loading of adenosine diphosphate receptor antagonists... 
Hematology, Oncology and Palliative Medicine | Primary percutaneous coronary intervention | Abciximab | Dual antiplatelet therapy | Platelet function | THROMBOSIS | REACTIVITY | TRIAL | CLOPIDOGREL | INTRACORONARY | THROMBOLYSIS | PERIPHERAL VASCULAR DISEASE | PRASUGREL | HEMATOLOGY | INTERVENTION | ELEVATION MYOCARDIAL-INFARCTION | AGGREGATION | Piperazines - administration & dosage | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Purinergic P2Y Receptor Antagonists - administration & dosage | Ticlopidine - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Thiophenes - administration & dosage | Immunoglobulin Fab Fragments - therapeutic use | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Ticlopidine - administration & dosage | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Drug Administration Routes | Administration, Oral | Blood Platelets | Piperazines - therapeutic use | Ticlopidine - analogs & derivatives | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Aged | Coronary heart disease | Cardiac patients
Journal Article
Clinical Research in Cardiology, ISSN 1861-0684, 2/2012, Volume 101, Issue 2, pp. 117 - 124
Journal Article
Atherosclerosis, ISSN 0021-9150, 2012, Volume 223, Issue 1, pp. 212 - 218
Journal Article
Journal Article
Cardiology Journal, ISSN 1897-5593, 2012, Volume 19, Issue 3, pp. 230 - 242
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2008, Volume 136, Issue 2, pp. 165 - 170
Abstract Background In the EASY trial, we have shown the clinical equivalence between abciximab bolus-only and abciximab bolus followed by 12-h infusion in a wide spectrum of patients... 
Cardiovascular | Abciximab | Intracoronary | Platelets | Stent | Transradial |